High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma.

[1]  R. Hay,et al.  Defective IκBα in Hodgkin cell lines with constitutively active NF-κB , 1998, Oncogene.

[2]  C. Mackay,et al.  Flexible Programs of Chemokine Receptor Expression on Human Polarized T Helper 1 and 2 Lymphocytes , 1998, The Journal of experimental medicine.

[3]  A. Mantovani,et al.  Identification of the CC chemokines TARC and macrophage inflammatory protein‐1β as novel functional ligands for the CCR8 receptor , 1998, European journal of immunology.

[4]  M. Baggiolini,et al.  CCR5 is characteristic of Th1 lymphocytes , 1998, Nature.

[5]  P. Allavena,et al.  Differential Expression of Chemokine Receptors and Chemotactic Responsiveness of Type 1 T Helper Cells (Th1s) and Th2s , 1998, The Journal of experimental medicine.

[6]  W. Chan,et al.  Clonality in nodular lymphocyte-predominant Hodgkin's disease. , 1997, The New England journal of medicine.

[7]  R. Schwartz.  Hodgkin's disease--time for a change. , 1997, The New England journal of medicine.

[8]  S. Pileri,et al.  Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells. , 1997, The New England journal of medicine.

[9]  M. Baggiolini,et al.  Identification of CCR8, the Receptor for the Human CC Chemokine I-309* , 1997, The Journal of Biological Chemistry.

[10]  O. Yoshie,et al.  The T Cell-directed CC Chemokine TARC Is a Highly Specific Biological Ligand for CC Chemokine Receptor 4* , 1997, The Journal of Biological Chemistry.

[11]  F. Herrmann,et al.  Hodgkin's disease: a tumor with disturbed immunological pathways. , 1997, Immunology today.

[12]  G. Pinkus,et al.  Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation? , 1997, The American journal of pathology.

[13]  K. Rajewsky,et al.  Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells , 1996, The Journal of experimental medicine.

[14]  S. Poppema,et al.  Immunology of Hodgkin's disease. , 1996, Bailliere's clinical haematology.

[15]  O. Yoshie,et al.  Molecular Cloning of a Novel T Cell-directed CC Chemokine Expressed in Thymus by Signal Sequence Trap Using Epstein-Barr Virus Vector* , 1996, The Journal of Biological Chemistry.

[16]  B. Dörken,et al.  High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells. , 1996, Blood.

[17]  V. Diehl,et al.  Molecular single cell analysis demonstrates the derivation of a peripheral blood-derived cell line (L1236) from the Hodgkin/Reed-Sternberg cells of a Hodgkin's lymphoma patient. , 1996, Blood.

[18]  O. Yoshie,et al.  Constitutive expression of various chemokine genes in human T‐cell lines infected with human T‐cell leukemia virus type 1: Role of the viral transactivator Tax , 1996, International journal of cancer.

[19]  H Stein,et al.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. , 1994, Blood.

[20]  S. Poppema.  The nature of the lymphocytes surrounding Reed-Sternberg cells in nodular lymphocyte predominance and in other types of Hodgkin's disease. , 1989, The American journal of pathology.

[21]  P. Sherrington,et al.  A Ki-1 (CD30)-positive human cell line (Karpas 299) established from a high-grade non-Hodgkin's lymphoma, showing a 2;5 translocation and rearrangement of the T-cell receptor beta-chain gene , 1988 .

[22]  S. Poppema,et al.  Nodular lymphocyte predominance type of Hodgkin's disease is a germinal center lymphoma. , 1986, Laboratory investigation; a journal of technical methods and pathology.

[23]  V. Diehl,et al.  Characteristics of Hodgkin's disease-derived cell lines. , 1982, Cancer treatment reports.

[24]  S. Poppema,et al.  CD45 (leucocyte common antigen) expression in T and B lymphocyte subsets. , 1996, Leukemia & lymphoma.